Skip to main content
Top
Published in: The Journal of Headache and Pain 2/2009

Open Access 01-04-2009 | Original

Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin

Authors: Fabiano C. Tanuri, Eliângela de Lima, Mario F. P. Peres, Francisco R. Cabral, Maria da Graça Naffah-Mazzacoratti, Esper Abrão Cavalheiro, José Cipolla-Neto, Eliova Zukerman, Débora Amado

Published in: The Journal of Headache and Pain | Issue 2/2009

Login to get access

Abstract

The aim of the present work was to analyze c-fos response within the trigeminal nucleus caudalis (TNC) of pinealectomized rats and animals that received intraperitoneal melatonin, after intracisternal infusion of capsaicin, used to induce intracranial trigeminovascular stimulation. Experimental groups consisted of animals that received vehicle solution (saline–ethanol–Tween 80, 8:1:1, diluted 1:50) only (VEI, n = 5); animals that received capsaicin solution (200 nM) only (CAP, n = 6); animals submitted to pinealectomy (PX, n = 5); sham-operated animals (SH, n = 5); animals submitted to pinealectomy followed by capsaicin stimulation (200 nM) after 15 days (PX + CAP, n = 7); and animals that received capsaicin solution (200 nM) and intraperitoneal melatonin (10 mg/kg) (CAP + MEL, n = 5). Control rats, receiving vehicle in the cisterna magna, showed a small number of c-fos-positive cells in the TNC (layer I/II) as well as the sham-operated and pinealectomized rats, when compared to animals stimulated by capsaicin. On the other hand, pinealectomized rats, which received capsaicin, presented the highest number of c-fos-positive cells. Animals receiving capsaicin and melatonin treatment had similar expression of the vehicle group. Our data provide experimental evidence to support the role of melatonin and pineal gland in the pathophysiology of neurovascular headaches.
Literature
1.
go back to reference Lipton RB, Stewart WF (1998) Migraine headaches: epidemiology and comorbidity. Clin Neurosci 5:2–9PubMed Lipton RB, Stewart WF (1998) Migraine headaches: epidemiology and comorbidity. Clin Neurosci 5:2–9PubMed
2.
5.
go back to reference Moskowitz MA (1990) Basic mechanisms in vascular headache. Neurol Clin 8:801–815PubMed Moskowitz MA (1990) Basic mechanisms in vascular headache. Neurol Clin 8:801–815PubMed
6.
go back to reference May A, Goadsby PJ (1999) The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 19:115–127CrossRefPubMed May A, Goadsby PJ (1999) The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 19:115–127CrossRefPubMed
7.
go back to reference Mayberg MR, Zervas NT, Moskowitz MA (1984) Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 223:46–56CrossRefPubMed Mayberg MR, Zervas NT, Moskowitz MA (1984) Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 223:46–56CrossRefPubMed
8.
go back to reference Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48–56CrossRefPubMed Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48–56CrossRefPubMed
9.
go back to reference Mitsikostas DD, Sanchez del Rio M (2001) Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res Brain Res Rev 35:20–35CrossRefPubMed Mitsikostas DD, Sanchez del Rio M (2001) Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res Brain Res Rev 35:20–35CrossRefPubMed
10.
go back to reference Shepheard SL, Williamson DJ, Williams J, Hill RG, Hargreaves RJ (1995) Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 34:255–261CrossRefPubMed Shepheard SL, Williamson DJ, Williams J, Hill RG, Hargreaves RJ (1995) Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 34:255–261CrossRefPubMed
11.
go back to reference Hargreaves RJ, Shepheard SL (1999) Pathophysiology of migraine—new insights. Can J Neurol Sci 26(Suppl 3):S12–S19CrossRefPubMed Hargreaves RJ, Shepheard SL (1999) Pathophysiology of migraine—new insights. Can J Neurol Sci 26(Suppl 3):S12–S19CrossRefPubMed
12.
go back to reference Kaube H, Hoskin KL, Goadsby PJ (1992) Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia 12:133–136CrossRefPubMed Kaube H, Hoskin KL, Goadsby PJ (1992) Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia 12:133–136CrossRefPubMed
13.
go back to reference Nozaki K, Boccalini P, Moskowitz MA (1992) Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience 49:669–680CrossRefPubMed Nozaki K, Boccalini P, Moskowitz MA (1992) Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience 49:669–680CrossRefPubMed
14.
go back to reference Sheng M, Greenberg ME (1990) The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4:477–485CrossRefPubMed Sheng M, Greenberg ME (1990) The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4:477–485CrossRefPubMed
15.
go back to reference Dragunow M, Robertson HA (1988) Brain injury induces c-fos protein(s) in nerve and glial-like cells in adult mammalian brain. Brain Res 455:295–299CrossRefPubMed Dragunow M, Robertson HA (1988) Brain injury induces c-fos protein(s) in nerve and glial-like cells in adult mammalian brain. Brain Res 455:295–299CrossRefPubMed
16.
go back to reference Nozaki K, Boccalini P, Moskowitz MA (1992) Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience 49:669–680CrossRefPubMed Nozaki K, Boccalini P, Moskowitz MA (1992) Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience 49:669–680CrossRefPubMed
17.
go back to reference Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ (1993) Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629:95–102CrossRefPubMed Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ (1993) Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629:95–102CrossRefPubMed
18.
go back to reference Nozaki K, Moskowitz MA, Boccalini P (1992) CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 106:409–415PubMedCentralCrossRefPubMed Nozaki K, Moskowitz MA, Boccalini P (1992) CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 106:409–415PubMedCentralCrossRefPubMed
19.
go back to reference Cutrer FM, Limmroth V, Ayata G, Moskowitz MA (1995) Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 116:3199–3204PubMedCentralCrossRefPubMed Cutrer FM, Limmroth V, Ayata G, Moskowitz MA (1995) Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 116:3199–3204PubMedCentralCrossRefPubMed
20.
go back to reference Reiter RJ (1986) Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J Neural Transm Suppl 21:35–54PubMed Reiter RJ (1986) Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J Neural Transm Suppl 21:35–54PubMed
21.
go back to reference Peres MF (2005) Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 25:403–411CrossRefPubMed Peres MF (2005) Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 25:403–411CrossRefPubMed
22.
go back to reference Peres MF, Rozen TD (2001) Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia 21:993–995CrossRefPubMed Peres MF, Rozen TD (2001) Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia 21:993–995CrossRefPubMed
23.
go back to reference Peres MF, Masruha MR, Zukerman E, Moreira-Filho CA, Cavalheiro EA (2006) Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opin Investig Drugs 15:367–375CrossRefPubMed Peres MF, Masruha MR, Zukerman E, Moreira-Filho CA, Cavalheiro EA (2006) Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opin Investig Drugs 15:367–375CrossRefPubMed
25.
go back to reference Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G (1996) Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 16:494–496CrossRefPubMed Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G (1996) Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 16:494–496CrossRefPubMed
26.
go back to reference Peres MF, Masruha MR, Young WB (2006) Side-shifting hemicrania continua with aura (migraine with aura with autonomic symptoms responsive to indomethacin?). Cephalalgia 26:917–919CrossRefPubMed Peres MF, Masruha MR, Young WB (2006) Side-shifting hemicrania continua with aura (migraine with aura with autonomic symptoms responsive to indomethacin?). Cephalalgia 26:917–919CrossRefPubMed
27.
go back to reference CIOMS (1985) CIOMS international guiding principles for biomedical research involving animals. Altern Lab Anim 12:ii CIOMS (1985) CIOMS international guiding principles for biomedical research involving animals. Altern Lab Anim 12:ii
28.
go back to reference Siuciak JA, Dubocovich ML (1993) Effect of pinealectomy and the light/dark cycle on 2-[125I]iodomelatonin binding in the chick optic tectum. Cell Mol Neurobiol 13:193–202CrossRefPubMed Siuciak JA, Dubocovich ML (1993) Effect of pinealectomy and the light/dark cycle on 2-[125I]iodomelatonin binding in the chick optic tectum. Cell Mol Neurobiol 13:193–202CrossRefPubMed
29.
go back to reference Consiglio AR, Lucion AB (2000) Technique for collecting cerebrospinal fluid in the cisterna magna of non-anesthetized rats. Brain Res Brain Res Protoc 5:109–114CrossRefPubMed Consiglio AR, Lucion AB (2000) Technique for collecting cerebrospinal fluid in the cisterna magna of non-anesthetized rats. Brain Res Brain Res Protoc 5:109–114CrossRefPubMed
30.
go back to reference Cutrer FM, Limmroth V, Ayata G, Moskowitz MA (1995) Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 116:3199–3204PubMedCentralCrossRefPubMed Cutrer FM, Limmroth V, Ayata G, Moskowitz MA (1995) Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 116:3199–3204PubMedCentralCrossRefPubMed
31.
go back to reference Ter Horst GJ, Meijler WJ, Korf J, Kemper RH (2001) Trigeminal nociception-induced cerebral Fos expression in the conscious rat. Cephalalgia 21:963–975CrossRefPubMed Ter Horst GJ, Meijler WJ, Korf J, Kemper RH (2001) Trigeminal nociception-induced cerebral Fos expression in the conscious rat. Cephalalgia 21:963–975CrossRefPubMed
32.
go back to reference Kemper RH, Meijler WJ, Ter Horst GJ (1997) Trigeminovascular stimulation in conscious rats. NeuroReport 8:1123–1126CrossRefPubMed Kemper RH, Meijler WJ, Ter Horst GJ (1997) Trigeminovascular stimulation in conscious rats. NeuroReport 8:1123–1126CrossRefPubMed
33.
go back to reference Steiger HJ, Meakin CJ (1984) The meningeal representation in the trigeminal ganglion—an experimental study in the cat. Headache 24:305–309CrossRefPubMed Steiger HJ, Meakin CJ (1984) The meningeal representation in the trigeminal ganglion—an experimental study in the cat. Headache 24:305–309CrossRefPubMed
35.
go back to reference Carrillo-Vico A, Garcia-Maurino S, Calvo JR, Guerrero JM (2003) Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J 17:755–757PubMed Carrillo-Vico A, Garcia-Maurino S, Calvo JR, Guerrero JM (2003) Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J 17:755–757PubMed
36.
go back to reference Peres MF, Masruha MR, Young WB (2006) Side-shifting hemicrania continua with aura (migraine with aura with autonomic symptoms responsive to indomethacin?). Cephalalgia 26:917–919CrossRefPubMed Peres MF, Masruha MR, Young WB (2006) Side-shifting hemicrania continua with aura (migraine with aura with autonomic symptoms responsive to indomethacin?). Cephalalgia 26:917–919CrossRefPubMed
37.
go back to reference Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuna-Castroviejo D, Guerrero JM (1996) Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 20:205–210CrossRefPubMed Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuna-Castroviejo D, Guerrero JM (1996) Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 20:205–210CrossRefPubMed
38.
go back to reference Kilic E, Ozdemir YG, Bolay H, Kelestimur H, Dalkara T (1999) Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 19:511–516CrossRefPubMed Kilic E, Ozdemir YG, Bolay H, Kelestimur H, Dalkara T (1999) Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 19:511–516CrossRefPubMed
39.
go back to reference de Lima E, Soares JM Jr, Carmen Sanabria GY, Gomes VS, Priel MR, Chada BE, Abrao CE, Graca Naffah-Mazzacoratti M, Amado D (2005) Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats. Brain Res 1043:24–31CrossRefPubMed de Lima E, Soares JM Jr, Carmen Sanabria GY, Gomes VS, Priel MR, Chada BE, Abrao CE, Graca Naffah-Mazzacoratti M, Amado D (2005) Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats. Brain Res 1043:24–31CrossRefPubMed
40.
go back to reference Brun J, Claustrat B, Saddier P, Chazot G (1995) Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia 15:136–139CrossRefPubMed Brun J, Claustrat B, Saddier P, Chazot G (1995) Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia 15:136–139CrossRefPubMed
41.
go back to reference Leone M, Lucini V, D’Amico D, Grazzi L, Moschiano F, Fraschini F, Bussone G (1998) Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache. Cephalalgia 18:664–667CrossRefPubMed Leone M, Lucini V, D’Amico D, Grazzi L, Moschiano F, Fraschini F, Bussone G (1998) Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache. Cephalalgia 18:664–667CrossRefPubMed
42.
go back to reference Miano S, Parisi P, Pelliccia A, Luchetti A, Paolino MC, Villa MP (2008) Melatonin to prevent migraine or tension-type headache in children. Neurol Sci 29:285–287CrossRefPubMed Miano S, Parisi P, Pelliccia A, Luchetti A, Paolino MC, Villa MP (2008) Melatonin to prevent migraine or tension-type headache in children. Neurol Sci 29:285–287CrossRefPubMed
43.
go back to reference Peres MF, Zukerman E, da Cunha TF, Moreira FR, Cipolla-Neto J (2004) Melatonin, 3 mg, is effective for migraine prevention. Neurology 63:757CrossRefPubMed Peres MF, Zukerman E, da Cunha TF, Moreira FR, Cipolla-Neto J (2004) Melatonin, 3 mg, is effective for migraine prevention. Neurology 63:757CrossRefPubMed
Metadata
Title
Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin
Authors
Fabiano C. Tanuri
Eliângela de Lima
Mario F. P. Peres
Francisco R. Cabral
Maria da Graça Naffah-Mazzacoratti
Esper Abrão Cavalheiro
José Cipolla-Neto
Eliova Zukerman
Débora Amado
Publication date
01-04-2009
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 2/2009
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-009-0097-3

Other articles of this Issue 2/2009

The Journal of Headache and Pain 2/2009 Go to the issue